Company to Deliver to Patients FDA-Approved Topical Treatment for Dystrophic Epidermolysis Bullosa (DEB)Announces Collaboration with Amedisys to Administer Treatment in the HomeBANNOCKBURN, Ill., May 23, 2023 (GLOBE
Option Care Health, Inc. (NASDAQ: OPCH) announced that an affiliate of Walgreens Boots Alliance, Inc. (the "Selling Stockholder") has agreed to sell 13,000,000 shares of the Company's common stock at a price to the public of $30.75 per share in an underwritten secondary offering.